Recall
FDAHealthSeptember 19, 2025

Ascend Laboratories, LLC — Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877-511-05), c). 1000-count bottle (NDC 67877-511-10) Man

⚠️ Failed Dissolution Specifications

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
September 19, 2025

U.S. Nationwide

What's affected?

Product
Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877-511-05), c). 1000-count bottle (NDC 67877-511-10) Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.
UPC
0367877512051
Lot code
25141249

Additional details

Lot#: 25141249, Exp. Feb. 2027 Lot#: 24144938, Exp. Nov. 2026 Lot#: 24144868, Exp. Nov. 2026 Lot#: 24144867, Exp. Nov. 2026 Lot#: 24144458, Exp. Sep. 2026 Lot#: 24143994, Exp. Sep. 2026 Lot#: 24142987, Exp. July 2026 Lot#: 24143316, Exp. July 2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 141,984 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.